Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
To assess whether dehydroepiandrostenedione (DHEA) substitution, superimposed on GH substitution, improves quality of life of patients with secondary adrenal failure, we studied the effects of DHEA (50 mg/d, 16 wk) vs. placebo (16 wk) in GH- and ACTH-deficient men (n = 15; age, 52 +/- 3 yr), and postmenopausal women (n = 16; age, 61 +/- 2 yr) in a double-blind, placebo-controlled, crossover study. All patients were receiving stable hormone replacement therapy, including a fixed dose of human recombinant GH during the study. The men received testosterone substitution. The female patients did not receive estrogen substitution. At baseline, multiple parameters of quality of life were impaired compared with age- and sex-matched controls, especially in female patients. These parameters were not improved by DHEA treatment. DHEA only slightly improved the depression score (women) and health perception (women and men), although these parameters were not abnormal at baseline. DHEA increased serum IGF-I concentrations in female patients (by approximately 18%; P < 0.001), but not in male patients. In neither group did DHEA affect IGF-binding protein-3 levels. We conclude that DHEA, superimposed on GH substitution, does not substantially improve quality of life in patients with secondary adrenal insufficiency regardless of gender. In addition, DHEA increases IGF-I levels only in estrogen-depleted females, but not in testosterone-treated males, with secondary adrenal insufficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which is in keeping with observations in some short- (20,48,54) and longer-term trials (25) but differs from observations in women with primary or secondary adrenal failure (23,24).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [54]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,653
Smets, E. M. A., Garssen, B., Bonke, B., & De Haes, J. C. J. M. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00125-o · Cited by 3,613
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158
The two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Baulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577
De Waal, M. W. M., Arnold, I. A., Eekhof, J. A. H., & Van Hemert, A. M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.470 · Cited by 533
Morales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
Cited by
Sexual dysfunction in men and women with endocrine disorders
Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60280-3 · Cited by 319
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282
Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 234
Miller, K. K., Biller, B. M. K., Beauregard, C., Lipman, J. G., Jones, J., Schoenfeld, D., Sherman, J. C., Swearingen, B., Loeffler, J., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2596 · Cited by 225
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e85c6 · Cited by 191
Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
Sexual Desire and Arousal Disorders in Women
Basson, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050154 · Cited by 189
DHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183
Alkatib, A. A., Cosma, M., Elamin, M. B., Erickson, D., Swiglo, B. A., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0672 · Cited by 147
Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma
Dekkers, O. M., van der Klaauw, A. A., Pereira, A. M., Biermasz, N. R., Honkoop, P. J., Roelfsema, F., Smit, J. W. A., & Romijn, J. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0003 · Cited by 124
Self-citationEndocrine Aspects of Women’s Sexual Function
Wierman, M. E., Nappi, R. E., Avis, N., Davis, S. R., Labrie, F., Rosner, W., & Shifren, J. L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01629.x · Cited by 123
Hypopituitarism: Clinical Features, Diagnosis, and Management
Toogood, A. A., & Stewart, P. M. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.004 · Cited by 120
DHEA for postmenopausal women: A review of the evidence
Panjari, M., & Davis, S. R. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.017 · Cited by 97
DHEA therapy for women: effect on sexual function and wellbeing
Panjari, M., & Davis, S. R. (2007) · Human Reproduction Update · doi:10.1093/humupd/dml055 · Cited by 94
Diagnosis and Treatment of Hypopituitarism: An Update
van Aken, M. O., & Lamberts, S. W. J. (2005) · Pituitary · doi:10.1007/s11102-006-6039-z · Cited by 71
Sexuality and Fertility in Women with Addison’s Disease
Erichsen, M. M., Husebye, E. S., Michelsen, T. M., Dahl, A. A., & Løvås, K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0445 · Cited by 67
Brooke, A. M., Kalingag, L. A., Miraki-Moud, F., Camacho-Hübner, C., Maher, K. T., Walker, D. M., Hinson, J. P., & Monson, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0316 · Cited by 63
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61
Binder, G., Weber, S., Ehrismann, M., Zaiser, N., Meisner, C., Ranke, M. B., Maier, L., Wudy, S. A., Hartmann, M. F., Heinrich, U., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1982 · Cited by 52
Powrie, Y. S. L., & Smith, C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1324-0 · Cited by 38
Should Dehydroepiandrosterone Be Administered to Women?
Wierman, M. E., & Kiseljak‐Vassiliades, K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac130 · Cited by 37
Serum IGF-I levels in the diagnosis and monitoring of acromegaly
Brooke, A. M., & Drake, W. M. (2007) · Pituitary · doi:10.1007/s11102-007-0036-8 · Cited by 35
Dehydroepiandrosterone and Bone
Zhou, S., & Glowacki, J. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.005 · Cited by 33
Health-related quality of life in primary and secondary adrenal insufficiency
Aulinas, A., & Webb, S. M. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.963559 · Cited by 32
Bentley, C., Hazeldine, J., Greig, C. A., Lord, J. M., & Foster, M. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0158-z · Cited by 32
The effects of dehydroepiandrosterone on sexual function: a systematic review
Peixoto, C., Carrilho, C. G., Barros, J. A., Ribeiro, T. T. S. B., Silva, L. M., Nardi, A. E., Cardoso, A., & Veras, A. B. (2017) · Climacteric · doi:10.1080/13697137.2017.1279141 · Cited by 30
Profka, E., Rodari, G., Giacchetti, F., & Giavoli, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.678778 · Cited by 27
DHEA: why, when, and how much – DHEA replacement in adrenal insufficiency
Allolio, B., Arlt, W., & Hahner, S. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.018 · Cited by 27
Christiansen, J. J., Bruun, J. M., Christiansen, J. S., Jørgensen, J. O., & Gravholt, C. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0289 · Cited by 26
Brooke, A. M., Kalingag, L. A., Miraki‐Moud, F., Camacho‐Hübner, C., Maher, K. T., Walker, D. M., Hinson, J. P., & Monson, J. P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02648.x · Cited by 25
Peixoto, C., Grande, A. J., Carrilho, C. G., Nardi, A. E., Cardoso, A., & Veras, A. B. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24721 · Cited by 18
Is DHEA replacement beneficial in chronic adrenal failure?
Lang, K., Burger‐Stritt, S., & Hahner, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.007 · Cited by 17
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 17
Dehydroepiandrosterone to Enhance Physical Performance: Myth and Reality
Hahner, S., & Allolio, B. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.10.008 · Cited by 17
Guidelines for diagnosis and treatment of adrenal insufficiency in adults
Novoa, P. D. M., Vela, E. T., García, N. P., Rodríguez, M. M., Guerras, I. S., Santamaría, M. D. L. Á. M. D. S., & Aulinas, A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(14)70069-8 · Cited by 16
McHenry, C. M., Bell, P. M., Hunter, S. J., Thompson, C. J., Courtney, C. H., Ennis, C. N., Sheridan, B., McCance, D. R., Mullan, K., & Atkinson, A. B. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04356.x · Cited by 11
Dehydroepiandrosterone replacement therapy
Arlt, W. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224811.39318.73 · Cited by 11
Hasenmajer, V., Alcubierre, D. D., Ferrari, D., Minnetti, M., Bonaventura, I., Pofi, R., Simeoli, C., Tomaselli, A., Sciarra, F., Bottillo, G., et al. (2024) · Andrology · doi:10.1111/andr.13635 · Cited by 10
Mandal, S., Mukhopadhyay, P., & Ghosh, S. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac260 · Cited by 10
Kasayama, S., Morita, S., Otsuki, M., Asanuma, N., Saito, H., Mukai, M., & Koga, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02815.x · Cited by 10
Female Sexual Dysfunction in Primary Adrenal Insufficiency
Zamponi, V., Lardo, P., Maggio, R., Simonini, C., Mazzilli, R., Faggiano, A., Pugliese, G., & Stigliano, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132767 · Cited by 9
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency
Bennett, G., Cussen, L., & O’Reilly, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000728 · Cited by 9
Substitution mit Nebennierensteroiden
Hahner, S., & Allolio, B. (2008) · Der Internist · doi:10.1007/s00108-008-2122-z · Cited by 8
Androgen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 7
Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
Zang, H., & Davis, S. R. (2008) · Drugs · doi:10.2165/00003495-200868150-00001 · Cited by 7
Çetin, S. A., & Aslan, E. (2020) · Sexual & Relationship Therapy · doi:10.1080/14681994.2020.1792875 · Cited by 6
Dehydroepiandrosterone and androstenedione
Allolio, B., Arlt, W., & Hahner, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.021 · Cited by 5
Treatment of corticotroph deficiency
Ouleghzal, H., Rosales, C., & Raffin‐Sanson, M. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.01.001 · Cited by 4
Dehydroepiandrosterone replacement therapy—panacea, snake oil, or a bit of both?
Chang, A. Y., Ghayee, H. K., & Auchus, R. J. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0870 · Cited by 4
Rabe, T., Hj, A., Albring, C., Bachmann, A., Bitzer, J., Blume‐Peytavi, U., Egarter, C., Hinney, B., Kentenich, H., König, K. G., et al. (2016) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency
Handelsman, D. J., Matsumoto, A. M., & GERRARD, D. F. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000300 · Cited by 3
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 2
Brooke, A. M., & Monson, J. P. (2012) · Clinical Endocrinology · doi:10.1111/cen.12080 · Cited by 1
Overvloed en onbehagen. Uitdagingen voor de moderne endocrinologie.
Smit, J. W. A. (2008) · Leiden Repository (Leiden University)
Self-citationFemale sexual dysfunction in hypopituitarism – Authors' reply
Schneider, H. J., Aimaretti, G., & Kreitschmann‐Andermahr, I. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61369-5
Hormone Replacement Therapy in Female Sexual Dysfunction
Yoon, H. (2012) · Korean Journal of Andrology · doi:10.5534/kja.2012.30.1.13
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Benoît, I., & Charbonnel, B. H. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.06.011
Whipple's disease and sarcoidosis
Jl, A., Kotz, K. J., Dennerstein, L., Kutner, S. J., & Wallen, K. (2007)
Endocrine Disorders During the First Year After Autologous Stem-Cell Transplant
Molitch, M. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70485-2
Golden, W. C., Bethea, J., McGrew, M., Hadley, M., Neill, K., Dickerson, L., Simmons, H., & Stallings, J. (2010)
Influence des médicaments sur la libido féminine
Grandvallet, A., & Gillet, P. (2008) · Publications Et Travaux Academiques de Lorraine (Universite de Lorraine)
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00035-7
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Abnormal growth hormone secretion : clinical aspects
Thiel, S. W. V. (2005) · Leiden Repository (Leiden University)
Metadata
- Authors
- van Thiel, S. W., Romijn, J. A., Pereira, A. M., Biermasz, N. R., Roelfsema, F., van Hemert, A., Ballieux, B., & Smit, J. W. A.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Smit, Johannes W. A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3295-3303
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2114955296
- Semantic Scholar
- 12ee86853fc2a549c706aa87ffd16d4e03405f3c
- Cited by
- 66
- References
- 37
- Citations by year
- 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 3 · 2014: 3 · 2013: 1 · 2012: 6
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- secondary adrenal insufficiency, insulin-like growth factor I, quality of life, IGF binding protein-3, ACTH deficiency, testosterone replacement therapy, postmenopausal women, depression, sex differences
- MeSH terms
- Adrenal Insufficiency, Adult, Anxiety, Depression, Fatigue, Female, Humans, Insulin-Like Growth Factor I, Male, Placebos, Quality of Life, Surveys and Questionnaires, Sexual Behavior, Dihydrotestosterone, Cross-Over Studies, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.